Jeffrey D. Forman

Papers

Total Citations

1,112

H-Index

About

Jeffrey D. Forman is a leading authority in the management of prostate cancer, with a career dedicated to advancing both clinical guidelines and therapeutic strategies. His primary research focuses on optimizing treatment for clinically localized prostate cancer, particularly through the development of evidence-based protocols that balance efficacy with quality of life. Forman’s most impactful contribution is his authorship of the "Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update," published in the *Journal of Urology*, which has garnered over 1,100 citations. This seminal work has shaped urological practice worldwide by providing a standardized framework for clinicians. Beyond this, his research has explored the interplay between prostate volume, biopsy cores, and 5α-reductase inhibitor therapy, offering critical insights into cancer detection probabilities. Forman’s work is distinguished by its direct translational impact, bridging rigorous clinical research with actionable patient care. With a citation count exceeding 1,100 for his landmark guideline alone, his legacy lies in empowering clinicians with tools to make informed, personalized decisions, ultimately improving outcomes for men facing prostate cancer.